May 2 (Reuters) - CSPC Pharmaceutical Group Ltd 1093.HK:
LETTERS OF INTENT ENTERED INTO BY ORIENT BIOTECH WITH UNITS OF CSPC PHARMACEUTICAL GROUP
OBJECTIVE OF LOI TO DEVELOP, OTHERS & EXPAND APPLICATIONS WITHIN FUNCTIONAL FOOD AND SUPPLEMENT SECTORS ACROSS REGIONAL MARKETS
Further company coverage: 1093.HK
((Reuters.Briefs@thomsonreuters.com;;))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。